Latest total current liabilities for SNPHF: $75B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), SNPHF shows a total current liabilities of $75B. That compares with $500M in the prior-year period — up 15023.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SNPHF's total current liabilities is now $75B (was $500M) — a 15023.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Santen Pharmaceutical , Ltd. is outperforming or lagging.
Tracking SNPHF's total current liabilities over time shows whether Santen Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $75B That compares with $500M in the prior-year period — up 15023.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total current liabilities page, Stockcircle has Santen Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $75B) with ownership activity and broader fundamentals.